Patients With Norepinephrine Refractory Vasoplegic Shock clinical trials

Explore recruiting patients with norepinephrine refractory vasoplegic shock clinical trials.

Recruiting patients with norepinephrine refractory vasoplegic shock studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Patients With Norepinephrine Refractory Vasoplegic Shock trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of early Argipressin (arginine vasopressin) in the management of intensive care patients with norepinephrine-refractory vasoplegic shock: a multicentric randomized, double-blind placebo-controlled superiority trial : Vaso²R

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Patients With Norepinephrine Refractory Vasoplegic Shock trials by city

Patients With Norepinephrine Refractory Vasoplegic Shock in Toronto Patients With Norepinephrine Refractory Vasoplegic Shock in Vancouver Patients With Norepinephrine Refractory Vasoplegic Shock in Montreal Patients With Norepinephrine Refractory Vasoplegic Shock in Calgary Patients With Norepinephrine Refractory Vasoplegic Shock in Edmonton Patients With Norepinephrine Refractory Vasoplegic Shock in Ottawa Patients With Norepinephrine Refractory Vasoplegic Shock in Winnipeg Patients With Norepinephrine Refractory Vasoplegic Shock in Quebec City Patients With Norepinephrine Refractory Vasoplegic Shock in Hamilton Patients With Norepinephrine Refractory Vasoplegic Shock in Kitchener Patients With Norepinephrine Refractory Vasoplegic Shock in London Patients With Norepinephrine Refractory Vasoplegic Shock in Halifax Patients With Norepinephrine Refractory Vasoplegic Shock in New York Patients With Norepinephrine Refractory Vasoplegic Shock in Los Angeles Patients With Norepinephrine Refractory Vasoplegic Shock in Chicago Patients With Norepinephrine Refractory Vasoplegic Shock in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease